{"database": "lobbying", "table": "lobbying_activities", "rows": [[2963228, "e3e3c44f-ada4-4240-bc15-eb44d4d0ff40", "Q1", "ASSOCIATION FOR ACCESSIBLE MEDICINES", 16032, "ASSOCIATION FOR ACCESSIBLE MEDICINES", 2023, "first_quarter", "CPT", "Patent Settlements. Patent Abuse. Skinny Labeling. Inter Partes Review. Impact of IPR decisions on 30-month stay. IPR Amendments. Cornyn-Leahy IPR Proposals. Patent Quality. Enhancing Quality of Patents through the Patent Trial and Appeal Board (PTAB). Patent Listings in Orange Book. S.79: Interagency Patent Coordination and Improvement Act of 2023. S.113: Prescription Pricing for the People Act of 2023. S.142: Preserve Access to Affordable Generics and Biosimilars Act. S.148: Stop STALLING Act. S.150: Affordable Prescriptions for Patients Act of 2023.", "HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Patent & Trademark Office (PTO),SENATE", null, 480000, 0, 0, "2023-04-18T08:48:45-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2963228"], "units": {}, "query_ms": 0.3460020016063936, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}